75 related articles for article (PubMed ID: 6986078)
1. Immunohistochemistry versus immunofluorescence for non-Hodgkin's lymphomas.
Tubbs RR; Sheibani K; Sebek BA; Weiss RA
Am J Clin Pathol; 1980 Jan; 73(1):144-5. PubMed ID: 6986078
[No Abstract] [Full Text] [Related]
2. Terminal deoxynucleotidyl transferase in non-Hodgkin's lymphoma.
Braziel RM; Keneklis T; Donlon JA; Hsu SM; Cossman J; Bollum FJ; Jaffe ES
Am J Clin Pathol; 1983 Nov; 80(5):655-9. PubMed ID: 6356870
[TBL] [Abstract][Full Text] [Related]
3. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease.
Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD
J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684
[TBL] [Abstract][Full Text] [Related]
4. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
5. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
6. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease.
Hyder DM; Schnitzer B
Arch Pathol Lab Med; 1986 May; 110(5):416-9. PubMed ID: 3516118
[TBL] [Abstract][Full Text] [Related]
7. [Immunoenzyme cytochemical methods, monoclonal antibodies and lectins in the diagnosis of tumors of the lymphoid tissue in children].
Gluzman DF; Nadgornaia VA; Skliarenko LM; Abramenko IV; Sidorenko SP; Kaz'mina EV; Livshits EA; Drozdova VD
Pediatriia; 1991; (11):18-22. PubMed ID: 1766734
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphoma following Hodgkin's disease. A case report and immunohistochemical corroboration.
Shimizu K; Hara K; Kunii A
Am J Clin Pathol; 1986 Sep; 86(3):370-4. PubMed ID: 3529930
[TBL] [Abstract][Full Text] [Related]
9. Biclonal gammopathy (IgG kappa and IgG lambda) in a patient with non-Hodgkin's lymphoma.
Guarner J; Austin GE; Nassar VH; Sarma PR; Boedecker E
Arch Pathol Lab Med; 1986 May; 110(5):445-8. PubMed ID: 3083801
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry of fresh-frozen lymphoid tissue with the direct immunoperoxidase technic.
Tubbs RR; Sheibani K; Weiss RA; Sebek BA
Am J Clin Pathol; 1981 Feb; 75(2):172-4. PubMed ID: 6781329
[TBL] [Abstract][Full Text] [Related]
11. Comparison of monoclonal and polyclonal antibodies directed against immunoglobulin light and heavy chains in non-Hodgkin's lymphoma.
Têtu B; Manning JT; Ordóñez NG
Am J Clin Pathol; 1986 Jan; 85(1):25-31. PubMed ID: 3079627
[TBL] [Abstract][Full Text] [Related]
12. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
Schmidt U; Herbst J; Metz KA; Leder LD
J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
[TBL] [Abstract][Full Text] [Related]
13. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Das Gupta A; Shah VI
Hematol Pathol; 1990; 4(1):37-41. PubMed ID: 2187855
[TBL] [Abstract][Full Text] [Related]
14. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
15. [Phenotypic and genotypic marker in malignant lymphomas: cellular origin of Hodgkin's disease and malignant histiocytosis as well as implications for classifying T-cell and B-cell lymphomas].
Stein H; Gerdes J
Verh Dtsch Ges Pathol; 1986; 70():127-51. PubMed ID: 3548121
[No Abstract] [Full Text] [Related]
16. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic difficulties of pure intrasinusoidal bone marrow infiltration of non-Hodgkin's lymphoma: a report of eight cases from India.
Das R; Sachdeva MU; Malhotra P; Das A; Ahluwalia J; Bal A; Jain S; Varma N; Varma S
Jpn J Clin Oncol; 2011 Nov; 41(11):1303-7. PubMed ID: 21940732
[TBL] [Abstract][Full Text] [Related]
18. Lymphoma associated antigen (LAA)--a unique biomarker for lymphomas.
Udayachander M; Meenakshi A; Sakthivel R; Sreenivasan R; Krishnan RH; Padma S
Indian J Biochem Biophys; 1991; 28(5-6):461-6. PubMed ID: 1812083
[TBL] [Abstract][Full Text] [Related]
19. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
[TBL] [Abstract][Full Text] [Related]
20. Use of monoclonal antibodies for analyzing the distribution of the intermediate filament protein vimentin in human non-Hodgkin's lymphomas.
Giorno R; Sciotto CG
Am J Pathol; 1985 Sep; 120(3):351-5. PubMed ID: 2412444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
